Also trades as: ACONW (NASDAQ) · $vol 0M
ACON NASDAQ
Aclarion, Inc.
1W: -8.1%
1M: +3.0%
3M: -22.5%
YTD: -52.2%
1Y: -68.6%
3Y: -100.0%
$2.38
-0.06 (-2.46%)
Weekly Expected Move ±10.9%
$2
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$6.9M
52W Range1.95-12.03
Volume15,748
Avg Volume68,196
Beta1.24
Dividend—
Analyst Ratings
Company Info
CEOBrent Ness
Employees11
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2022-04-22
Websiteaclarion.com
8181 Arista Place
Broomfield, CA 80021
US
Broomfield, CA 80021
US
650-241-1741
About Aclarion, Inc.
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.
Latest News
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates
Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Williams Amanda M | P-Purchase | 5,857 | $2.73 | 2026-08-17 |
| Gould Gregory A | P-Purchase | 10,000 | $2.45 | 2026-08-14 |
| Bond Ryan | P-Purchase | 21,122 | $2.37 | 2026-08-13 |
| Wesemann William | P-Purchase | 2,150 | $2.34 | 2026-08-13 |
| Neal David K | P-Purchase | 7,500 | $2.40 | 2026-08-13 |